HKG Equity Snapshot
6955 Weekly Equity Report
Shandong Boan Biotechnology Co., Ltd.
What the company does
Shandong Boan Biotechnology Co., Ltd., a biopharmaceutical company, develops, manufactures, and markets biologics in Mainland China. The company offers Boyounuo (BA1101), an anti-VEGF humanized monoclonal antibody injection for mCRC, advanced metastatic or recurrent non-small cell lung cancer, recurrent glioblastoma, epithelial ovarian, fallopian tube, primary peritoneal cancer, cervical cancer, and hepatocellular carcinoma indications; Boyoubei (BA6101), a human immunoglobulin G2 monoclonal antibody of the RANK ligand for the treatment of postmenopausal and male osteoporosis; and Boluojia (BA1102), a fully human IgG2 anti-RANKL monoclonal antibody to treat bone metastases from solid tumors, and giant cell tumor of bone. …
What the weekly tape is saying
6955 closed the latest completed week at 5.00 HKD. The 4-week return is -16.4% and the 12-week return is -24.2%. Trend Signal is inactive, Market Dynamics is -0.57. Setup signature: Risk-first tape with a 16/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 7.61 HKD
- Vs Trend Line
- -34.3%
- Fair Value
- 10.91 HKD
- Vs Fair Value
- -54.2%
- 52W High
- 19.90 HKD
- 52W Low
- 4.54 HKD
- Drawdown
- -74.9%
- Range Position
- 3.0%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 0 weeks
- 52W Active Weeks
- 16
- 52W Active Breadth
- 30.8%
- Sector Scope
- HK Healthcare
- Sector Rank
- 155 of 257
- Sector Percentile
- 39.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
HK Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- -1.3%
- Avg 4W
- -12.8%
- Trend Breadth
- 6.0%
- Positive MD
- 10.0%
HK Biotechnology
- Tracked Peers
- 76
- 4W Rank
- 31 of 76
- Avg 1W
- -1.6%
- Avg 4W
- -17.5%
- Trend Breadth
- 3.9%
- Positive RS
- 5.3%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- -0.57
- 4W MD Change
- -5.1%
- Relative Strength
- -48.77
- 4W RS Change
- -9.2%
- Expectation
- Negative
- Probability
- 38.42%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 26.2M
- 13W Average
- 28.9M
- 52W Average
- 46.7M
- Vs 13W
- 0.9x
- Vs 52W
- 0.6x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 4.6%
- 52W Volatility
- 6.7%
- Upside Weeks
- 16
- Downside Weeks
- 36
- Downside Breadth
- 69.2%
- Avg Gain / Loss
- 6.5% / -5.3%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- HKG
- Country
- HK
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- HKD
- Market Cap
- 3.6B
Opportunity signals
- No strong opportunity cluster is confirmed yet; monitor trend and Market Dynamics.
Risk signals
- Trend Signal is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Market Dynamics is negative, which weakens the current setup.
- The share remains more than 20% below its 52-week high.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 5.00 HKD | -2.7% | 7.61 HKD | 10.91 HKD | -0.57 | -48.77 | 26.2M | Off |
| 5 Jun 2026 | 5.14 HKD | -10.3% | 7.81 HKD | 10.97 HKD | -0.48 | -48.77 | 23.5M | Off |
| 29 May 2026 | 5.73 HKD | -5.4% | 7.97 HKD | 11.03 HKD | -0.37 | -44.09 | 22.7M | Off |
| 22 May 2026 | 6.06 HKD | 1.3% | 8.13 HKD | 11.09 HKD | -0.29 | -42.61 | 102.3M | Off |
| 15 May 2026 | 5.98 HKD | -8.8% | 8.28 HKD | 11.15 HKD | -0.54 | -44.66 | 15.4M | Off |
| 8 May 2026 | 6.56 HKD | -4.1% | 8.46 HKD | 11.21 HKD | -0.61 | -40.74 | 9.8M | Off |
| 1 May 2026 | 6.84 HKD | 4.0% | 8.65 HKD | 11.27 HKD | -0.57 | -37.20 | 18.6M | Off |
| 24 Apr 2026 | 6.58 HKD | -6.1% | 8.84 HKD | 11.34 HKD | -0.56 | -40.61 | 16.2M | Off |
| 17 Apr 2026 | 7.01 HKD | -2.0% | 9.04 HKD | 11.40 HKD | -0.43 | -37.81 | 22.4M | Off |
| 10 Apr 2026 | 7.15 HKD | 2.4% | 9.27 HKD | 11.46 HKD | -0.46 | -36.97 | 19.4M | Off |
| 3 Apr 2026 | 6.98 HKD | 2.2% | 9.46 HKD | 11.54 HKD | -0.60 | -36.89 | 47.0M | Off |
| 27 Mar 2026 | 6.83 HKD | 3.5% | 9.67 HKD | 11.62 HKD | -0.74 | -38.17 | 41.3M | Off |
| 20 Mar 2026 | 6.60 HKD | -6.5% | 9.90 HKD | 11.70 HKD | -0.87 | -41.28 | 11.5M | Off |
| 13 Mar 2026 | 7.06 HKD | -2.8% | 10.22 HKD | 11.79 HKD | -0.92 | -37.98 | 16.4M | Off |